| Helen Ann Jones, RPH | |
|
1703 Fremont Dr, Canon City, CO 81212-2405 | |
| (719) 275-3319 | |
| Not Available |
| Full Name | Helen Ann Jones |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1703 Fremont Dr, Canon City, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639452832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15771 (Colorado) | Primary |
| 183500000X | Pharmacist | 18359 (Iowa) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Helen Ann Jones, RPH 1703 Fremont Dr, Canon City, CO 81212-2405 Ph: (719) 275-3319 | Helen Ann Jones, RPH 1703 Fremont Dr, Canon City, CO 81212-2405 Ph: (719) 275-3319 |
News Archive
The most important factor in what kind of sweetener people prefer has little to do with how sweet it tastes. Rather, it has more to do with other tastes in the sweetener, such as bitterness or sourness, new research suggests.
Two specialist laboratories opening night at the University of Sydney will shed light on the impact of sleep and circadian disruption in medical disorders and shift-workers, and the neurobiological mechanisms underlying substance abuse and depression.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
› Verified 6 days ago
Dr. Alicia Hurst, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3105 E Hwy 50, Canon City, CO 81212 Phone: 719-275-1641 | |
Nathan Cruz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 Main St, Canon City, CO 81212 Phone: 719-275-7511 Fax: 719-275-7161 | |
Brielle M Larsen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1609 Fremont Dr, Canon City, CO 81212 Phone: 719-275-1267 | |
Daniel Allen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1609 Fremont Dr, Canon City, CO 81212 Phone: 719-274-1267 | |
Dr. William A Shelver, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Main St, Canon City, CO 81212 Phone: 719-275-3375 Fax: 719-275-4756 | |
Mr. Kent Goulding Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 Main St, Canon City, CO 81212 Phone: 719-275-5221 | |
Jon Steven Atwood, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 Main St, Canon City, CO 81212 Phone: 719-275-7511 Fax: 719-275-7161 |